Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Minimizing Sample Failure Rates for Challenging Clinical Tumor Samples.

The Journal of molecular diagnostics : JMD - 1 May 2023

Fink J Lynn, Jaradi Binny, Stone Nathan, Anderson Lisa, Leo Paul J, Marshall Mhairi, Ellis Jonathan, Waring Paul M, O'Byrne Kenneth

Abstract excerpt

Identification of somatic variants in cancer by high-throughput sequencing has become common clinical practice, largely because many of these variants may be predictive biomarkers for targeted therapies. However, there can be high sample quality control (QC) failure rates for some tests that prevent the return of results. Stem-loop inhibition mediated amplification (SLIMamp) is a patented technology that has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Formaldehyde

Share to High-Throughput Nucleotide Sequencing

Share to Neoplasms

Share to Paraffin Embedding

Share to Tissue Fixation

Source

Identifiers

PMID: 36773702
DOI: 10.1016/j.jmoldx.2023.01.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Minimizing Sample Failure Rates for Challenging Clinical Tumor Samples.PMID 36773702Read ↗

Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology.Semantic proximity Read ↗

Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS)Semantic proximity Read ↗

Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.Semantic proximity Read ↗

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing–Based Oncology AssaysSemantic proximity Read ↗

Deep oncopanel sequencing reveals fixation time- and within block position-dependent quality degradation in FFPE processed samplesSemantic proximity Read ↗

Patient attrition in Molecular Tumour Boards: A ReviewSemantic proximity Read ↗

An interlaboratory study of complex variant detectionSemantic proximity Read ↗

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health.Semantic proximity Read ↗

Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.